Impact of COVID-19 Pandemic on Patients with Serious Mental Illness (SMI) and Nonpsychiatric Control Subjects in Clinical Trials
by Maria Fe Garcia-Rada, MPS, and Robert E. Litman, MD Ms. Fe Garcia-Rada and Dr. Litman are with CenExel CBH Health in Gaithersburg, Maryland. Dr. Litman is additionally with Georgetown University Medical School in Washington, DC. Funding: No funding was provided for this article. Disclosures: The authors have no conflicts of interest relevant to the [...]
The post Impact of COVID-19 Pandemic on Patients with Serious Mental Illness (SMI) and Nonpsychiatric Control Subjects in Clinical Trials appeared first on Innovations in Clinical Neuroscience.
Source: Innovations in Clinical Neuroscience - Category: Neuroscience Authors: ICNS Online Editor Tags: Current Issue Original Research Psychiatry clinical trials Source Type: research
More News: Brain | Clinical Trials | COVID-19 | Funding | Men | Neurology | Neuroscience | Pandemics | Psychiatry